Search research articles
Contact Us
Filters
Showing results (21-30 of 58) with videos related to
Page
of 6
Sort By:
Journal of Chemotherapy (Florence, Italy)
|
March 22, 2014
Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience
Ananthakrishnan Ramani, George Udeani, John Evans, et al.
The Journal of Antimicrobial Chemotherapy
|
April 13, 2011
Review of ceftaroline fosamil microbiology: integrated FOCUS studies
Ian A Critchley, Paul B Eckburg, Alena Jandourek, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 5, 2018
Assessment of a Statistical Algorithm for the Prediction of Benign Paroxysmal Positional Vertigo
Christopher J Britt, Bryan K Ward, Yaw Owusu, et al.
The Laryngoscope
|
October 23, 2024
Socioeconomic Determinants of Health and Reflux Management: Insights from a Tertiary Medical Center
Neil K Osafo, Jonathan M Bock, Joel H Blumin, et al.
American Journal of Surgery
|
December 20, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures
Samuel E Wilson, William O'Riordan, Alan Hopkins, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 31, 2015
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)
David J Guervil, Keith S Kaye, Ali Hassoun, et al.
Therapeutics and Clinical Risk Management
|
April 22, 2015
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
Christy Maggiore, Jose A Vazquez, David J Guervil, et al.
The Pediatric Infectious Disease Journal
|
April 15, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia
Jeffrey L Blumer, Tina Ghonghadze, Christopher Cannavino, et al.
Journal of Clinical and Translational Science
|
October 20, 2025
Integrated clinical research ensembles: A pathway to increased academic productivity
Sergey Tarima, John R Meurer, David Friedland, et al.
Plos One
|
December 21, 2017
High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features
Tala Achkar, Ananth Arjunan, Hong Wang, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 58) with videos related to
Sort By:
Page
of 6
Journal of Chemotherapy (Florence, Italy)
|
March 22, 2014
Contemporary use of ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia: CAPTURE study experience
Ananthakrishnan Ramani, George Udeani, John Evans, et al.
The Journal of Antimicrobial Chemotherapy
|
April 13, 2011
Review of ceftaroline fosamil microbiology: integrated FOCUS studies
Ian A Critchley, Paul B Eckburg, Alena Jandourek, et al.
JAMA Otolaryngology-- Head & Neck Surgery
|
September 5, 2018
Assessment of a Statistical Algorithm for the Prediction of Benign Paroxysmal Positional Vertigo
Christopher J Britt, Bryan K Ward, Yaw Owusu, et al.
The Laryngoscope
|
October 23, 2024
Socioeconomic Determinants of Health and Reflux Management: Insights from a Tertiary Medical Center
Neil K Osafo, Jonathan M Bock, Joel H Blumin, et al.
American Journal of Surgery
|
December 20, 2008
Telavancin versus vancomycin for the treatment of complicated skin and skin-structure infections associated with surgical procedures
Samuel E Wilson, William O'Riordan, Alan Hopkins, et al.
Journal of Chemotherapy (Florence, Italy)
|
March 31, 2015
Ceftaroline fosamil as first-line versus second-line treatment for acute bacterial skin and skin structure infections (ABSSSI) or community-acquired bacterial pneumonia (CABP)
David J Guervil, Keith S Kaye, Ali Hassoun, et al.
Therapeutics and Clinical Risk Management
|
April 22, 2015
Ceftaroline fosamil for the treatment of community-acquired bacterial pneumonia in the intensive care unit
Christy Maggiore, Jose A Vazquez, David J Guervil, et al.
The Pediatric Infectious Disease Journal
|
April 15, 2016
A Multicenter, Randomized, Observer-blinded, Active-controlled Study Evaluating the Safety and Effectiveness of Ceftaroline Compared With Ceftriaxone Plus Vancomycin in Pediatric Patients With Complicated Community-acquired Bacterial Pneumonia
Jeffrey L Blumer, Tina Ghonghadze, Christopher Cannavino, et al.
Journal of Clinical and Translational Science
|
October 20, 2025
Integrated clinical research ensembles: A pathway to increased academic productivity
Sergey Tarima, John R Meurer, David Friedland, et al.
Plos One
|
December 21, 2017
High-dose interleukin 2 in patients with metastatic renal cell carcinoma with sarcomatoid features
Tala Achkar, Ananth Arjunan, Hong Wang, et al.
Page
of 6